LaserSight sells subsidiaries for $13 million:
This article was originally published in Clinica
LaserSight has sold two of its health service subsidiaries, MEC Health Care and LSI Acquisition, to the eye care practice management company Vision Twenty-One for $13 million. Half the price will be paid in cash at closing and half in common stock, said LaserSight. The US company is working on the LSX platform for refractive surgery and said it would use $3.5 million of the net proceeds to repay loans.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.